Ben Isaacson
Analyst · Scotiabank
I just have 3 questions. The first one is on the SPN business. You are -- you have announced an increase in your guidance for a 10% growth in volume versus about 2% to 3% before. And you've talked about really taking share away from China in Asian markets. Can you just provide some color as to what's going on in China that's causing them to focus more on their domestic market? And how sustainable do you think this is? Pablo Altimiras Ben, Pablo Altimiras is speaking. Yes, that's right. We pretend to increase our volumes in 10%, as you said. This is more related with increasing potassium nitrate sales. As you know, by the end of March, China suspends the export of potassium nitrate abroad. So, that means that allow us to go to markets where we normally are not going. That opened an opportunity to put more volume in the market, and that explains mainly our growth. Regarding what's going on in China, well, it's difficult to say. In China also, you see that today it's not the only restriction in that product, potassium nitrate. You have other products that are restricted. So it's no easy to see what will happen in the future. However, in the meantime, we have the opportunity. We are well prepared because we have the capacity, the installed capacity, inventories and our supply chain worldwide ready if the market needs more potassium nitrate. Great. And my next question is on iodine. We've had elevated prices for quite some time. And if we go back, I can't remember how long it was, maybe 12 years ago, I can't remember. But when prices were at this level again at this level, it didn't last that long, and we saw supply coming to market and then we saw prices dropping. What gives you the confidence? And I know supply is coming to market slowly, but what gives you the confidence that we won't see an acceleration in supply of iodine over the next 2 or 3 years that will disrupt this pricing environment? Pablo Altimiras Well, I would say that, first of all, I mean, if you try to compare the market today with what the market 10, 12 years ago, it's too much high. I think that it's not so easy to compare. The market is much higher than before. Also, the participation of the different applications has changed. I mean, today, you have a more, for example, much more importance of X-ray contrast media that didn't happen before. So today, let's say, that you have some changes in the market. Also, what we have seen is that marginal projects are not there. But when they arrive, normally, they are higher cost than before. So that also puts some pressure in the price structure, let's say. And today, well, we are confident because a matter of supply and demand. In Q1, we saw a very strong demand. We believe that the market growth in Q1 more than 3%. So that sustained that we believe that this year, the market will grow 3%, sorry. And in the meantime, that happened and the supply is not there, we believe that, well, everything is there to remain this level of prices. And then my final question is on Salar Futuro. Can you just remind us what the CapEx spend looks like and the timing of the outflow? And the real question is to do with inflation, whether it's the impact of what's happened in -- with respect to the Iran war or whether it's tariffs or whether it's general inflation, we're seeing CapEx for projects around the world increase. So can you talk about what impact inflation is going to have on the Salar Futuro project and how that could impact returns?